Protagonist Therapeutics, Inc: cash_and_equivalents
| Value | {"amount": 28629000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-03-31) |
| Status | current |
| Entity | Protagonist Therapeutics, Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:14:35.942684+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9505930d-eefc-493e-9240-ba7692c1ff83
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001377121-17-000003Retrieved: 2026-08-19T13:14:35.942684+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001377121/cash-and-equivalents/2016-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9505930d-eefc-493e-9240-ba7692c1ff83
History
- no predecessors — first report